Unknown

Dataset Information

0

Genetic dissection of mammalian ERAD through comparative haploid and CRISPR forward genetic screens.


ABSTRACT: The application of forward genetic screens to cultured human cells represents a powerful method to study gene function. The repurposing of the bacterial CRISPR/Cas9 system provides an effective method to disrupt gene function in mammalian cells, and has been applied to genome-wide screens. Here, we compare the efficacy of genome-wide CRISPR/Cas9-mediated forward genetic screens versus gene-trap mutagenesis screens in haploid human cells, which represent the existing 'gold standard' method. This head-to-head comparison aimed to identify genes required for the endoplasmic reticulum-associated degradation (ERAD) of MHC class I molecules. The two approaches show high concordance (>70%), successfully identifying the majority of the known components of the canonical glycoprotein ERAD pathway. Both screens also identify a role for the uncharacterized gene TXNDC11, which we show encodes an EDEM2/3-associated disulphide reductase. Genome-wide CRISPR/Cas9-mediated screens together with haploid genetic screens provide a powerful addition to the forward genetic toolbox.

SUBMITTER: Timms RT 

PROVIDER: S-EPMC4906395 | biostudies-literature | 2016 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetic dissection of mammalian ERAD through comparative haploid and CRISPR forward genetic screens.

Timms Richard T RT   Menzies Sam A SA   Tchasovnikarova Iva A IA   Christensen Lea C LC   Williamson James C JC   Antrobus Robin R   Dougan Gordon G   Ellgaard Lars L   Lehner Paul J PJ  

Nature communications 20160610


The application of forward genetic screens to cultured human cells represents a powerful method to study gene function. The repurposing of the bacterial CRISPR/Cas9 system provides an effective method to disrupt gene function in mammalian cells, and has been applied to genome-wide screens. Here, we compare the efficacy of genome-wide CRISPR/Cas9-mediated forward genetic screens versus gene-trap mutagenesis screens in haploid human cells, which represent the existing 'gold standard' method. This  ...[more]

Similar Datasets

| S-EPMC5798846 | biostudies-literature
| S-EPMC4964798 | biostudies-literature
| S-EPMC3382162 | biostudies-literature
| S-EPMC6350973 | biostudies-literature
| S-EPMC5983209 | biostudies-literature
| S-EPMC4481156 | biostudies-literature
| S-EPMC9072436 | biostudies-literature
| S-EPMC9067404 | biostudies-literature
| S-EPMC7821101 | biostudies-literature
| S-EPMC5015935 | biostudies-literature